Skip to main content

Resveratrol as a Therapeutic Agent for Neurodegenerative Diseases


Excess production of reactive oxygen species in the brain has been implicated as a common underlying risk factor for the pathogenesis of a number of neurodegenerative disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), and stroke. In recent years, there is considerable interest concerning investigation of antioxidative and anti-inflammatory effects of phenolic compounds from different botanical sources. In this review, we first describe oxidative mechanisms associated with stroke, AD, and PD, and subsequently, we place emphasis on recent studies implicating neuroprotective effects of resveratrol, a polyphenolic compound derived from grapes and red wine. These studies show that the beneficial effects of resveratrol are not only limited to its antioxidant and anti-inflammatory action but also include activation of sirtuin 1 (SIRT1) and vitagenes, which can prevent the deleterious effects triggered by oxidative stress. In fact, SIRT1 activation by resveratrol is gaining importance in the development of innovative treatment strategies for stroke and other neurodegenerative disorders. The goal here is to provide a better understanding of the mode of action of resveratrol and its possible use as a potential therapeutic agent to ameliorate stroke damage as well as other age-related neurodegenerative disorders.

This is a preview of subscription content, access via your institution.

Fig. 1


  1. 1.

    Beckman KB, Ames BN (1998) The free radical theory of aging matures. Physiol Rev 78:547–581

    CAS  PubMed  Google Scholar 

  2. 2.

    Harman AW, Maxwell MJ (1995) An evaluation of the role of calcium in cell injury. Annu Rev Pharmacol Toxicol 35:129–144

    CAS  PubMed  Article  Google Scholar 

  3. 3.

    Perez-Campo R, Lopez-Torres M, Cadenas S, Rojas C, Barja G (1998) The rate of free radical production as a determinant of the rate of aging: evidence from the comparative approach. J Comp Physiol [B] 168:149–158

    CAS  Google Scholar 

  4. 4.

    Sun AY, Wang Q, Simonyi A, Sun GY (2008) Botanical phenolics and brain health. Neuromolecular Med 10:259–274

    CAS  PubMed  Article  Google Scholar 

  5. 5.

    Farooqui T, Farooqui AA (2009) Aging: an important factor for the pathogenesis of neurodegenerative diseases. Mech Ageing Dev 130:203–215

    CAS  PubMed  Article  Google Scholar 

  6. 6.

    Rice-Evans C, Miller N (1997) Measurement of the antioxidant status of dietary constituents, low density lipoproteins and plasma. Prostaglandins Leukot Essent Fatty Acids 57:499–505

    CAS  PubMed  Article  Google Scholar 

  7. 7.

    Martin S, Andriambeloson E, Takeda K, Andriantsitohaina R (2002) Red wine polyphenols increase calcium in bovine aortic endothelial cells: a basis to elucidate signalling pathways leading to nitric oxide production. Br J Pharmacol 135:1579–1587

    CAS  PubMed  Article  Google Scholar 

  8. 8.

    Ndiaye M, Chataigneau M, Lobysheva I, Chataigneau T, Schini-Kerth VB (2005) Red wine polyphenol-induced, endothelium-dependent NO-mediated relaxation is due to the redox-sensitive PI3-kinase/Akt-dependent phosphorylation of endothelial NO-synthase in the isolated porcine coronary artery. Faseb J 19:455–457

    CAS  PubMed  Google Scholar 

  9. 9.

    Albani D, Polito L, Batelli S, De Mauro S, Fracasso C, Martelli G, Colombo L, Manzoni C, Salmona M, Caccia S, Negro A, Forloni G (2009) The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide. J Neurochem 110:1445–1456

    CAS  PubMed  Article  Google Scholar 

  10. 10.

    Sinclair DA (2005) Toward a unified theory of caloric restriction and longevity regulation. Mech Ageing Dev 126:987–1002

    CAS  PubMed  Article  Google Scholar 

  11. 11.

    Allard JS, Perez E, Zou S, de Cabo R (2009) Dietary activators of Sirt1. Mol Cell Endocrinol 299:58–63

    CAS  PubMed  Article  Google Scholar 

  12. 12.

    Anderson R, Prolla T (2009) PGC-1alpha in aging and anti-aging interventions. Biochim Biophys Acta 1790:1059–1066

    CAS  PubMed  Google Scholar 

  13. 13.

    Csiszar A, Labinskyy N, Pinto JT, Ballabh P, Zhang H, Losonczy G, Pearson K, de Cabo R, Pacher P, Zhang C, Ungvari Z (2009) Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol 297:H13–H20

    CAS  PubMed  Article  Google Scholar 

  14. 14.

    Calabrese V, Cornelius C, Mancuso C, Barone E, Calafato S, Bates T, Rizzarelli E, Kostova AT (2009) Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases. Front Biosci 14:376–397

    CAS  PubMed  Article  Google Scholar 

  15. 15.

    Calabrese V, Cornelius C, Mancuso C, Pennisi G, Calafato S, Bellia F, Bates TE, Giuffrida Stella AM, Schapira T, Dinkova Kostova AT, Rizzarelli E (2008) Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem Res 33:2444–2471

    CAS  PubMed  Article  Google Scholar 

  16. 16.

    Traystman RJ (2003) Animal models of focal and global cerebral ischemia. ILAR J 44:85–95

    CAS  PubMed  Google Scholar 

  17. 17.

    Bravo L (1998) Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 56:317–333

    CAS  PubMed  Article  Google Scholar 

  18. 18.

    Voko Z, Hollander M, Hofman A, Koudstaal PJ, Breteler MM (2003) Dietary antioxidants and the risk of ischemic stroke: the Rotterdam Study. Neurology 61:1273–1275

    CAS  PubMed  Google Scholar 

  19. 19.

    Youdim KA, Joseph JA (2001) A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects. Free Radic Biol Med 30:583–594

    CAS  PubMed  Article  Google Scholar 

  20. 20.

    Deschamps V, Barberger-Gateau P, Peuchant E, Orgogozo JM (2001) Nutritional factors in cerebral aging and dementia: epidemiological arguments for a role of oxidative stress. Neuroepidemiology 20:7–15

    CAS  PubMed  Article  Google Scholar 

  21. 21.

    Simonyi A, Wang Q, Miller RL, Yusof M, Shelat PB, Sun AY, Sun GY (2005) Polyphenols in cerebral ischemia: novel targets for neuroprotection. Mol Neurobiol 31:135–147

    CAS  PubMed  Article  Google Scholar 

  22. 22.

    Curin Y, Ritz MF, Andriantsitohaina R (2006) Cellular mechanisms of the protective effect of polyphenols on the neurovascular unit in strokes. Cardiovasc Hematol Agents Med Chem 4:277–288

    CAS  PubMed  Article  Google Scholar 

  23. 23.

    Selkoe DJ, Podlisny MB (2002) Deciphering the genetic basis of Alzheimer's disease. Annu Rev Genom Hum Genet 3:67–99

    CAS  Article  Google Scholar 

  24. 24.

    Tanzi RE, Bertram L (2005) Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120:545–555

    CAS  PubMed  Article  Google Scholar 

  25. 25.

    Selkoe DJ (2001) Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis 3:75–80

    CAS  PubMed  Google Scholar 

  26. 26.

    Reddy PH, Beal MF (2005) Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res Brain Res Rev 49:618–632

    CAS  PubMed  Article  Google Scholar 

  27. 27.

    de la Monte SM, Wands JR (2005) Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J Alzheimers Dis 7:45–61

    PubMed  Google Scholar 

  28. 28.

    Qiu WQ, Folstein MF (2006) Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis. Neurobiol Aging 27:190–198

    CAS  PubMed  Article  Google Scholar 

  29. 29.

    Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, Hersh LB, Sapolsky RM, Mirnics K, Sisodia SS (2005) Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120:701–713

    CAS  PubMed  Article  Google Scholar 

  30. 30.

    Tchantchou F, Chan A, Kifle L, Ortiz D, Shea TB (2005) Apple juice concentrate prevents oxidative damage and impaired maze performance in aged mice. J Alzheimers Dis 8:283–287

    CAS  PubMed  Google Scholar 

  31. 31.

    Selkoe DJ (2004) Alzheimer disease: mechanistic understanding predicts novel therapies. Ann Intern Med 140:627–638

    CAS  PubMed  Google Scholar 

  32. 32.

    Caughey B, Lansbury PT (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26:267–298

    CAS  PubMed  Article  Google Scholar 

  33. 33.

    Shelat PB, Chalimoniuk M, Wang JH, Strosznajder JB, Lee JC, Sun AY, Simonyi A, Sun GY (2008) Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons. J Neurochem 106:45–55

    CAS  PubMed  Article  Google Scholar 

  34. 34.

    Butterfield DA, Reed T, Newman SF, Sultana R (2007) Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med 43:658–677

    CAS  PubMed  Article  Google Scholar 

  35. 35.

    Langston JW (1987) MPTP: insights into the etiology of Parkinson's disease. Eur Neurol 26(Suppl 1):2–10

    CAS  PubMed  Article  Google Scholar 

  36. 36.

    Tipton KF, Singer TP (1993) Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J Neurochem 61:1191–1206

    CAS  PubMed  Article  Google Scholar 

  37. 37.

    Sun AY, Yang WL, Kim HD (1993) Free radical and lipid peroxidation in manganese-induced neuronal cell injury. Ann N Y Acad Sci 679:358–363

    CAS  PubMed  Article  Google Scholar 

  38. 38.

    Koshimura I, Imai H, Hidano T, Endo K, Mochizuki H, Kondo T, Mizuno Y (1997) Dimethoxyphenylethylamine and tetrahydropapaverine are toxic to the nigrostriatal system. Brain Res 773:108–116

    CAS  PubMed  Article  Google Scholar 

  39. 39.

    Miller RL, James-Kracke M, Sun GY, Sun AY (2009) Oxidative and inflammatory pathways in Parkinson's disease. Neurochem Res 34:55–65

    CAS  PubMed  Article  Google Scholar 

  40. 40.

    Miller RL, Sun GY, Sun AY (2007) Cytotoxicity of paraquat in microglial cells: involvement of PKCdelta- and ERK1/2-dependent NADPH oxidase. Brain Res 1167:129–139

    CAS  PubMed  Article  Google Scholar 

  41. 41.

    Oldfield FF, Cowan DL, Sun AY (1991) The involvement of ethanol in the free radical reaction of 6-hydroxydopamine. Neurochem Res 16:83–87

    CAS  PubMed  Article  Google Scholar 

  42. 42.

    Sun AY, Chen YM, James-Kracke M, Wixom P, Cheng Y (1997) Ethanol-induced cell death by lipid peroxidation in PC12 cells. Neurochem Res 22:1187–1192

    CAS  PubMed  Article  Google Scholar 

  43. 43.

    Loeber S, Duka T, Welzel H, Nakovics H, Heinz A, Flor H, Mann K (2009) Impairment of cognitive abilities and decision making after chronic use of alcohol: the impact of multiple detoxifications. Alcohol Alcohol 44:372–381

    CAS  PubMed  Google Scholar 

  44. 44.

    Moselhy HF, Georgiou G, Kahn A (2001) Frontal lobe changes in alcoholism: a review of the literature. Alcohol Alcohol 36:357–368

    CAS  PubMed  Google Scholar 

  45. 45.

    Simonyi A, Zhang JP, Sun AY, Sun GY (1996) Chronic ethanol on mRNA levels of IP3R1, IP3 3-kinase and mGluR1 in mouse Purkinje neurons. NeuroReport 7:2115–2118

    CAS  PubMed  Article  Google Scholar 

  46. 46.

    Simonyi A, Woods D, Sun AY, Sun GY (2002) Grape polyphenols inhibit chronic ethanol-induced COX-2 mRNA expression in rat brain. Alcohol Clin Exp Res 26:352–357

    CAS  PubMed  Google Scholar 

  47. 47.

    Crews FT, Nixon K (2009) Mechanisms of neurodegeneration and regeneration in alcoholism. Alcohol Alcohol 44:115–127

    CAS  PubMed  Google Scholar 

  48. 48.

    Lev N, Ickowicz D, Barhum Y, Melamed E, Offen D (2009) DJ-1 changes in G93A-SOD1 transgenic mice: implications for oxidative stress in ALS. J Mol Neurosci 38:94–102

    CAS  PubMed  Article  Google Scholar 

  49. 49.

    Muyderman H, Hutson PG, Matusica D, Rogers ML, Rush RA (2009) The human G93A-superoxide dismutase-1 mutation, mitochondrial glutathione and apoptotic cell death. Neurochem Res 34:1847–1856

    CAS  PubMed  Article  Google Scholar 

  50. 50.

    Lunn JS, Hefferan MP, Marsala M, Feldman EL (2009) Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery. Growth Factors 27:133–140

    CAS  PubMed  Article  Google Scholar 

  51. 51.

    Zagami CJ, Beart PM, Wallis N, Nagley P, O'Shea RD (2009) Oxidative and excitotoxic insults exert differential effects on spinal motoneurons and astrocytic glutamate transporters: implications for the role of astrogliosis in amyotrophic lateral sclerosis. Glia 57:119–135

    PubMed  Article  Google Scholar 

  52. 52.

    Gil JM, Rego AC (2008) Mechanisms of neurodegeneration in Huntington's disease. Eur J NeuroSci 27:2803–2820

    PubMed  Article  Google Scholar 

  53. 53.

    Sun AY, Simonyi A, Sun GY (2002) The “French Paradox” and beyond: neuroprotective effects of polyphenols. Free Radic Biol Med 32:314–318

    CAS  PubMed  Article  Google Scholar 

  54. 54.

    Sun AY, Sun GY (2001) Ethanol and oxidative mechanisms in the brain. J Biomed Sci 8:37–43

    CAS  PubMed  Article  Google Scholar 

  55. 55.

    Esposito E, Rotilio D, Di Matteo V, Di Giulio C, Cacchio M, Algeri S (2002) A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes. Neurobiol Aging 23:719–735

    CAS  PubMed  Article  Google Scholar 

  56. 56.

    Chanvitayapongs S, Draczynska-Lusiak B, Sun AY (1997) Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. NeuroReport 8:1499–1502

    CAS  PubMed  Article  Google Scholar 

  57. 57.

    Sun GY, Xia J, Draczynska-Lusiak B, Simonyi A, Sun AY (1999) Grape polyphenols protect neurodegenerative changes induced by chronic ethanol administration. NeuroReport 10:93–96

    CAS  PubMed  Article  Google Scholar 

  58. 58.

    Sun GY, Xia J, Xu J, Allenbrand B, Simonyi A, Rudeen PK, Sun AY (1999) Dietary supplementation of grape polyphenols to rats ameliorates chronic ethanol-induced changes in hepatic morphology without altering changes in hepatic lipids. J Nutr 129:1814–1819

    CAS  PubMed  Google Scholar 

  59. 59.

    Collins MA, Zou JY, Neafsey EJ (1998) Brain damage due to episodic alcohol exposure in vivo and in vitro: furosemide neuroprotection implicates edema-based mechanism. FASEB J 12:221–230

    CAS  PubMed  Google Scholar 

  60. 60.

    Crews FT, Bechara R, Brown LA, Guidot DM, Mandrekar P, Oak S, Qin L, Szabo G, Wheeler M, Zou J (2006) Cytokines and alcohol. Alcohol Clin Exp Res 30:720–730

    CAS  PubMed  Article  Google Scholar 

  61. 61.

    Ranney A, Petro MS (2009) Resveratrol protects spatial learning in middle-aged C57BL/6 mice from effects of ethanol. Behav Pharmacol 20:330–336

    CAS  PubMed  Article  Google Scholar 

  62. 62.

    Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY, Sun AY (2002) Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res 958:439–447

    CAS  PubMed  Article  Google Scholar 

  63. 63.

    Kriz J, Lalancette-Hebert M (2009) Inflammation, plasticity and real-time imaging after cerebral ischemia. Acta Neuropathol 117:497–509

    CAS  PubMed  Article  Google Scholar 

  64. 64.

    Wang Q, Simonyi A, Li W, Sisk BA, Miller RL, Macdonald RS, Lubahn DE, Sun GY, Sun AY (2005) Dietary grape supplement ameliorates cerebral ischemia-induced neuronal death in gerbils. Mol Nutr Food Res 49:443–451

    CAS  PubMed  Article  Google Scholar 

  65. 65.

    Wang Q, Sun AY, Simonyi A, Miller DK, Smith RE, Luchtefeld RG, Korthuis RJ, Sun GY (2009) Oral administration of grape polyphenol extract ameliorates cerebral ischemia/reperfusion-induced neuronal damage and behavioral deficits in gerbils: comparison of pre- and post-ischemic administration. J Nutr Biochem 20:369–377

    CAS  PubMed  Article  Google Scholar 

  66. 66.

    Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev 5:493–506

    CAS  Google Scholar 

  67. 67.

    Sharma M, Gupta YK (2002) Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci 71:2489–2498

    CAS  PubMed  Article  Google Scholar 

  68. 68.

    Ono K, Naiki H, Yamada M (2006) The development of preventives and therapeutics for Alzheimer's disease that inhibit the formation of beta-amyloid fibrils (fAbeta), as well as destabilize preformed fAbeta. Curr Pharm Des 12:4357–4375

    CAS  PubMed  Article  Google Scholar 

  69. 69.

    Ono K, Yamada M (2006) Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro. J Neurochem 97:105–115

    CAS  PubMed  Article  Google Scholar 

  70. 70.

    Marambaud P, Zhao H, Davies P (2005) Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J Biol Chem 280:37377–37382

    CAS  PubMed  Article  Google Scholar 

  71. 71.

    Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA, Sui G, Armour SM, Puigserver P, Sinclair DA, Tsai LH (2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 26:3169–3179

    CAS  PubMed  Article  Google Scholar 

  72. 72.

    Wang J, Ho L, Zhao Z, Seror I, Humala N, Dickstein DL, Thiyagarajan M, Percival SS, Talcott ST, Pasinetti GM (2006) Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease. Faseb J 20:2313–2320

    CAS  PubMed  Article  Google Scholar 

  73. 73.

    Lu KT, Ko MC, Chen BY, Huang JC, Hsieh CW, Lee MC, Chiou RY, Wung BS, Peng CH, Yang YL (2008) Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J Agric Food Chem 56:6910–6913

    CAS  PubMed  Article  Google Scholar 

  74. 74.

    Jin F, Wu Q, Lu YF, Gong QH, Shi JS (2008) Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. Eur J Pharmacol 600:78–82

    CAS  PubMed  Article  Google Scholar 

  75. 75.

    Barber SC, Higginbottom A, Mead RJ, Barber S, Shaw PJ (2009) An in vitro screening cascade to identify neuroprotective antioxidants in ALS. Free Radic Biol Med 46:1127–1138

    CAS  PubMed  Article  Google Scholar 

  76. 76.

    Kumar P, Padi SS, Naidu PS, Kumar A (2006) Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms. Behav Pharmacol 17:485–492

    CAS  PubMed  Article  Google Scholar 

  77. 77.

    Ates O, Cayli S, Altinoz E, Gurses I, Yucel N, Sener M, Kocak A, Yologlu S (2007) Neuroprotection by resveratrol against traumatic brain injury in rats. Mol Cell Biochem 294:137–144

    CAS  PubMed  Article  Google Scholar 

  78. 78.

    Sonmez U, Sonmez A, Erbil G, Tekmen I, Baykara B (2007) Neuroprotective effects of resveratrol against traumatic brain injury in immature rats. Neurosci Lett 420:133–137

    PubMed  Article  CAS  Google Scholar 

  79. 79.

    Rasouri S, Lagouge M, Auwerx J (2007) SIRT1/PGC-1: a neuroprotective axis? Med Sci (Paris) 23:840–844

    Google Scholar 

  80. 80.

    Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191–196

    CAS  PubMed  Article  Google Scholar 

  81. 81.

    Lamming DW, Wood JG, Sinclair DA (2004) Small molecules that regulate lifespan: evidence for xenohormesis. Mol Microbiol 53:1003–1009

    CAS  PubMed  Article  Google Scholar 

  82. 82.

    Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D (2004) Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430:686–689

    CAS  PubMed  Article  Google Scholar 

  83. 83.

    Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337–342

    CAS  PubMed  Article  Google Scholar 

  84. 84.

    Dasgupta B, Milbrandt J (2007) Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci USA 104:7217–7222

    CAS  PubMed  Article  Google Scholar 

  85. 85.

    Pallas M, Casadesus G, Smith MA, Coto-Montes A, Pelegri C, Vilaplana J, Camins A (2009) Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection. Curr Neurovasc Res 6:70–81

    CAS  PubMed  Article  Google Scholar 

  86. 86.

    Fuenzalida K, Quintanilla R, Ramos P, Piderit D, Fuentealba RA, Martinez G, Inestrosa NC, Bronfman M (2007) Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis. J Biol Chem 282:37006–37015

    CAS  PubMed  Article  Google Scholar 

  87. 87.

    Sundararajan S, Gamboa JL, Victor NA, Wanderi EW, Lust WD, Landreth GE (2005) Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience 130:685–696

    CAS  PubMed  Article  Google Scholar 

  88. 88.

    Wu JS, Cheung WM, Tsai YS, Chen YT, Fong WH, Tsai HD, Chen YC, Liou JY, Shyue SK, Chen JJ, Chen YE, Maeda N, Wu KK, Lin TN (2009) Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation. Circulation 119:1124–1134

    CAS  PubMed  Article  Google Scholar 

  89. 89.

    Rubiolo JA, Mithieux G, Vega FV (2008) Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur J Pharmacol 591:66–72

    CAS  PubMed  Article  Google Scholar 

  90. 90.

    Tang BL, Chua CE (2008) SIRT1 and neuronal diseases. Mol Aspects Med 29:187–200

    CAS  PubMed  Article  Google Scholar 

  91. 91.

    Lin TN, Wang Q, Simonyi A, Chen JJ, Cheung WM, He YY, Xu J, Sun AY, Hsu CY, Sun GY (2004) Induction of secretory phospholipase A2 in reactive astrocytes in response to transient focal cerebral ischemia in the rat brain. J Neurochem 90:637–645

    CAS  PubMed  Article  Google Scholar 

  92. 92.

    Bi XL, Yang JY, Dong YX, Wang JM, Cui YH, Ikeshima T, Zhao YQ, Wu CF (2005) Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. International immunopharmacology 5:185–193

    CAS  PubMed  Article  Google Scholar 

  93. 93.

    Kim YA, Lim SY, Rhee SH, Park KY, Kim CH, Choi BT, Lee SJ, Park YM, Choi YH (2006) Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in beta-amyloid-treated C6 glioma cells. Int J Mol Med 17:1069–1075

    CAS  PubMed  Google Scholar 

  94. 94.

    Robb EL, Winkelmolen L, Visanji N, Brotchie J, Stuart JA (2008) Dietary resveratrol administration increases MnSOD expression and activity in mouse brain. Biochem Biophys Res Commun 372:254–259

    CAS  PubMed  Article  Google Scholar 

  95. 95.

    Chen CY, Jang JH, Li MH, Surh YJ (2005) Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Commun 331:993–1000

    CAS  PubMed  Article  Google Scholar 

  96. 96.

    Anekonda TS (2006) Resveratrol—a boon for treating Alzheimer's disease? Brain Res Rev 52:316–326

    CAS  PubMed  Article  Google Scholar 

  97. 97.

    Mancuso C, Bates TE, Butterfield DA, Calafato S, Cornelius C, De Lorenzo A, Dinkova Kostova AT, Calabrese V (2007) Natural antioxidants in Alzheimer's disease. Expert Opin Investig Drugs 16:1921–1931

    CAS  PubMed  Article  Google Scholar 

  98. 98.

    de la Lastra CA, Villegas I (2007) Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans 35:1156–1160

    PubMed  Article  Google Scholar 

  99. 99.

    Qian YP, Cai YJ, Fan GJ, Wei QY, Yang J, Zheng LF, Li XZ, Fang JG, Zhou B (2009) Antioxidant-based lead discovery for cancer chemoprevention: the case of resveratrol. J Med Chem 52:1963–1974

    CAS  PubMed  Article  Google Scholar 

  100. 100.

    Saiko P, Szakmary A, Jaeger W, Szekeres T (2008) Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat Res 658:68–94

    CAS  PubMed  Article  Google Scholar 

  101. 101.

    Conte A, Pellegrini S, Tagliazucchi D (2003) Effect of resveratrol and catechin on PC12 tyrosine kinase activities and their synergistic protection from beta-amyloid toxicity. Drugs Exp Clin Res 29:243–255

    CAS  PubMed  Google Scholar 

  102. 102.

    Conte A, Pellegrini S, Tagliazucchi D (2003) Synergistic protection of PC12 cells from beta-amyloid toxicity by resveratrol and catechin. Brain Res Bull 62:29–38

    CAS  PubMed  Article  Google Scholar 

Download references


This work was supported in part by NIH grant 2P01 AG018357.

Author information



Corresponding author

Correspondence to Albert Y. Sun.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sun, A.Y., Wang, Q., Simonyi, A. et al. Resveratrol as a Therapeutic Agent for Neurodegenerative Diseases. Mol Neurobiol 41, 375–383 (2010).

Download citation


  • Neurodegenerative disorders
  • Stroke
  • Resveratrol
  • Antioxidant
  • Anti-inflammatory
  • SIRT1
  • Ischemia/reperfusion
  • Polyphenols
  • Mitochondria dysfunction
  • Apoptosis